About the Authors

Midori Hasegawa

Roles Conceptualization, Data curation, Methodology, Writing – original draft, Writing – review & editing

mhase@fujita-hu.ac.jp

Affiliation Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

Jin Iwasaki

Roles Data curation, Investigation, Methodology, Writing – original draft

Affiliation Tokoname City Hospital, Tokoname, Aichi, Japan

Satoshi Sugiyama

Roles Investigation

Affiliation Kanayama Clinic, Nagoya, Aichi, Japan

Takuma Ishihara

Roles Formal analysis

Affiliation Gifu University Hospital Innovative and Clinical Research Promotion Center, Gifu City, Gifu, Japan

Yoshihiro Yamamoto

Roles Investigation

Affiliation Toyota Memorial Hospital, Toyota, Aichi, Japan

Hiroaki Asada

Roles Investigation

Affiliation Okazaki City Hospital, Okazaki, Aichi, Japan

Shigehisa Koide

Roles Investigation

Affiliation Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

Hiroki Hayashi

Roles Validation

Affiliation Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

Kazuo Takahashi

Roles Validation

Affiliations Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan, Department of Biomedical Molecular Sciences, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

Daijo Inaguma

Roles Supervision

Affiliation Department of Internal Medicine, Fujita Health University Bantane Hospital, Nagoya, Japan

Yukio Yuzawa

Roles Supervision

Affiliation Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

Naotake Tsuboi

Roles Supervision

Affiliation Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

Competing Interests

I have read the journal's policy and have reported potential conflicts of interest outside the present work: M Hasegawa received lecture fees from Takeda Pharmaceutical Co., Ltd., Sanofi Co., Ltd., Mitsubishi Tanabe Pharma Co., Ltd., Chugai Pharmaceutical Co., Ltd. and Sumitomo Dainippon Pharma Co., Ltd. D Inaguma received lecture fees from Ono Pharmaceutical Co., Ltd. and Kyowa Kirin Co., Ltd.. Y Yuzawa received consigned research fund from Kyowa Kirin Co., Ltd. and Japan Tobacco Inc. and research support grants from Asahi Kasei Medical Co., Ltd., Astellas Pharma Inc., Baxter Ltd., Bayer Yakuhin Ltd., Chugai Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., ltd., Otsuka Pharmaceutical Co., Ltd., Pfizer Japan Inc., Sumitomo Dainippon Pharma Co., Ltd., Teijin Pharma Limited., Terumo Co., and Torii Pharmaceutical Co., Ltd.. N Tsuboi received the consigned research fund from Kyowa Kirin Co., Ltd. and Novartis Pharma K.K. and research support grants from Otsuka Pharmaceutical Co., Asahi Kasei Medical Co., Ltd., Baxter Ltd., Bayer Yakuhin, Ltd., Chugai Pharmaceutical Co., Ltd., and Torii Pharmaceutical Co., Ltd.. There are no other relevant declarations related to employment, consultancy, patents, products in development or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.